# Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia

Study · id `cardio:ct-nct02314663` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02314663](<https://clinicaltrials.gov/study/NCT02314663>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02314663

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 358 participants.

## Technical summary

Registry record NCT02314663. Randomized; single masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 358 participants (planned count; ClinicalTrials.gov record NCT02314663, source copy `cardio:ctgov-nct02314663-2014-12-11`, retrieved 2026-10-31)
- Start date: 2013-01 (registry gives no type) (ClinicalTrials.gov record NCT02314663, source copy `cardio:ctgov-nct02314663-2014-12-11`, retrieved 2026-10-31)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT02314663, source copy `cardio:ctgov-nct02314663-2014-12-11`, retrieved 2026-10-31)
- Completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT02314663, source copy `cardio:ctgov-nct02314663-2014-12-11`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02314663-2014-12-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia
- Acronym: EFESCOM
- Condition: Hypercholesterolemia
- Condition: Medication Adherence
- Condition: Primary Health Care
- Intervention (Device): "COMBINED STRATEGY"
- Lead sponsor: Gerencia de Atención Primaria, Albacete
- Lead sponsor class: OTHER
- Collaborator: Instituto de Salud Carlos III
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry lists this organization as a collaborator: Instituto de Salud Carlos III (`cardio:org-instituto-de-salud-carlos-iii`)

## Provenance

Content hash: edc9088b836ae63c336984196b8c3720a33d534f5233a70be87ac6839a740ee2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
